Immunome
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Immunome's balance sheet done over the years? Its assets were worth $148,540,000 last year, which is more than in the previous period. 19% of Immunome’s total assets is currently financed by debt. Its liabilities reached the amount of $28,658,000, which means an increase by 288% compared compared to last year.

Debt to Assets

Immunome, Inc. (NASDAQ:IMNM): Debt to assets
2018 4448000 29.65M 666.66%
2019 5060000 40.69M 804.15%
2020 44525000 3.18M 7.14%
2021 57925000 9.74M 16.81%
2022 24046000 7.39M 30.75%
2023 148540000 28.65M 19.29%

IMNM Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
98.67M20.32M49.22M39.76M2.54M1.60M
Short term investments
39.46M00000
Net receivables
289K847K4.31M900K00
Inventory
0-847K-4.31M-900K00
Other current assets
6.27M2.32M7.40M3.12M579K509K
Total current assets
144.70M22.64M56.63M42.89M3.12M2.11M
Non-current assets:
Property, Plant and Equipment
3.63M965K855K1.53M1.7M2.08M
Goodwill
000000
Intangible assets
000000
Long term investments
100K100K100K100K100K0
Other non-current assets
100K332K332K0138K255K
Total non-current assets
3.83M1.39M1.28M1.63M1.93M2.33M
Total assets
148.54M24.04M57.92M44.52M5.06M4.44M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
10.49M0-317K000
Short term debt
310K293K317K479K451K612K
Total current liabilities
21.82M7.33M9.72M3.03M1.66M1.56M
Non-current liabilities:
Long term debt
1.34M62K0134K113K564K
Deferred tax
000000
Other non-current liabilities
0012K8K38.91M27.52M
Total non-current liabilities
6.82M62K12K142K39.02M28.09M
Total liabilities
28.65M7.39M9.74M3.18M40.69M29.65M
Data sourceData sourceData sourceData source